Corcept Therapeutics (CORT) Posts Wider than Expected Q4 loss of 12c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $83.25 --0%
EPS Growth %: -96.6%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: -96.6%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q4 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Nomura/Instinet Upgrades SK Innovation Co Ltd (096770:KS) to Neutral
- Global Net Lease (GNL) Reiterated at Market Outperform by Citizens Amid De-leveraging
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
